Creative Biolabs Expands Microbiome Research Solutions

New focus on next-gen probiotics and stable postbiotics to address metabolic, gastrointestinal, and oncological challenges.

Published on Feb. 17, 2026

Got story updates? Submit your updates here. ›

Creative Biolabs, a leading contract research organization (CRO), has announced the expansion of its comprehensive service suite dedicated to the microbiome. By integrating cutting-edge Next-Generation Probiotics (NGPs) and highly stable postbiotics, the company is setting new benchmarks in the development of Live Biotherapeutic Products (LBPs) to address various health challenges.

Why it matters

The strategic shift towards postbiotics and functional metabolites represents a significant advancement in microbiome therapeutics. Unlike live bacteria, postbiotics offer superior stability and bioavailability, making them ideal for applications in functional foods, supplements, and cosmeceuticals. This expansion positions Creative Biolabs as a pioneer in the development of next-generation microbiome-based solutions.

The details

Creative Biolabs is focusing on postbiotics, the beneficial byproducts produced by probiotics, which offer superior stability and resistance to heat and stomach acid. The company has also fortified its analytical development and qualification services for live biotherapeutic products, employing advanced technologies like 16S rRNA sequencing and metabolomic profiling to ensure safety and efficacy standards. Additionally, Creative Biolabs continues to lead in microbiome therapeutics research, targeting high-potential species such as Akkermansia muciniphila and Faecalibacterium prausnitzii.

  • Creative Biolabs announced the expansion of its microbiome service suite on February 16, 2026.

The players

Creative Biolabs

A leading contract research organization (CRO) specializing in microbial research and drug discovery, with ISO 9001:2015 certification and world-renowned scientists.

Candy Swift

The media contact person for Creative Biolabs.

Got photos? Submit your photos here. ›

What they’re saying

“The industry is moving beyond just delivering live cultures. Our goal is to provide targeted, bioavailable metabolites that directly support the gut barrier and immune modulation. Postbiotics represent the future of stable, fast-acting microbiome interventions.”

— Technical Director (Creative Biolabs)

The takeaway

Creative Biolabs' expansion into next-generation probiotics and stable postbiotics positions the company as a leader in the development of innovative microbiome-based solutions, with the potential to address a wide range of metabolic, gastrointestinal, and oncological challenges.